- Home
- CRVO vs ELTK Comparison
CRVO vs ELTK Comparison
Compare CRVO & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- ELTK
- Stock Information
- Founded
- CRVO 2001
- ELTK 1970
- Country
- CRVO United States
- ELTK Israel
- Employees
- CRVO N/A
- ELTK N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- ELTK Electrical Products
- Sector
- CRVO Health Care
- ELTK Technology
- Exchange
- CRVO Nasdaq
- ELTK Nasdaq
- Market Cap
- CRVO 67.4M
- ELTK 69.5M
- IPO Year
- CRVO N/A
- ELTK 1997
- Fundamental
- Price
- CRVO $5.56
- ELTK $10.39
- Analyst Decision
- CRVO Strong Buy
- ELTK
- Analyst Count
- CRVO 8
- ELTK 0
- Target Price
- CRVO $25.57
- ELTK N/A
- AVG Volume (30 Days)
- CRVO 137.9K
- ELTK 39.6K
- Earning Date
- CRVO 08-08-2025
- ELTK 08-14-2025
- Dividend Yield
- CRVO N/A
- ELTK 1.87%
- EPS Growth
- CRVO N/A
- ELTK N/A
- EPS
- CRVO N/A
- ELTK 0.51
- Revenue
- CRVO $9,308,215.00
- ELTK $47,500,000.00
- Revenue This Year
- CRVO N/A
- ELTK $18.60
- Revenue Next Year
- CRVO N/A
- ELTK $9.04
- P/E Ratio
- CRVO N/A
- ELTK $20.01
- Revenue Growth
- CRVO 15.14
- ELTK 1.05
- 52 Week Low
- CRVO $1.80
- ELTK $7.65
- 52 Week High
- CRVO $20.63
- ELTK $12.19
- Technical
- Relative Strength Index (RSI)
- CRVO 30.87
- ELTK 52.74
- Support Level
- CRVO $6.31
- ELTK $10.27
- Resistance Level
- CRVO $7.20
- ELTK $11.69
- Average True Range (ATR)
- CRVO 0.53
- ELTK 0.74
- MACD
- CRVO -0.10
- ELTK -0.01
- Stochastic Oscillator
- CRVO 0.00
- ELTK 52.12
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.